Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cold Water Immersion Modulates Reinforcing Effects of Nitrous Oxide - 2

This study has been completed.
Sponsor:
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
University of Chicago
ClinicalTrials.gov Identifier:
NCT00000250
First received: September 20, 1999
Last updated: May 26, 2015
Last verified: May 2015
  Purpose
The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide. Mood altering and psychomotor effects will be tested on non-drug abusers and preference procedures will be used to assess reinforcing effects. To evaluate: cold water immersion modulates the reinforcing effects of nitrous oxide in healthy volunteers.

Condition Intervention Phase
Opioid-Related Disorders
Substance-Related Disorders
Drug: 0% N2O
Drug: 40% N2O
Phase 2

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
Official Title: Cold Water Immersion Modulates Reinforcing Effects of Nitrous Oxide

Resource links provided by NLM:


Further study details as provided by University of Chicago:

Primary Outcome Measures:
  • Subject's choice of intervention [ Time Frame: After sampling trials ] [ Designated as safety issue: No ]

Enrollment: 12
Study Start Date: December 1993
Study Completion Date: May 1995
Primary Completion Date: May 1995 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Lukewarm water
Subjects will immerse forearm in lukewarm water while inhaling 0% and 40% N2O in 2 sampling trials, then choose between intervntions for one choice trial
Drug: 0% N2O
Subjects will inhale 100% oxygen with no N2O for 25 min then immerse forearm in warm water and cold water
Drug: 40% N2O
Subjects will inhale 40% N2O then immerse forearm in warm water and cold water
Active Comparator: Ice cold water
Subjects will immerse forearm in ice cold water while inhaling 0% and 40% N2O in 2 sampling trials, then choose between intervntions for one choice trial
Drug: 0% N2O
Subjects will inhale 100% oxygen with no N2O for 25 min then immerse forearm in warm water and cold water
Drug: 40% N2O
Subjects will inhale 40% N2O then immerse forearm in warm water and cold water

  Eligibility

Ages Eligible for Study:   21 Years to 32 Years   (Adult)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria
Please contact site for information.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000250

Locations
United States, Illinois
University of Chicago, Anesthesia & Critical Care
Chicago, Illinois, United States, 60637
Sponsors and Collaborators
University of Chicago
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: James Zacny, Ph.D. University of Chicago
  More Information

Publications:
Experimentall Clinical Psycopharmacoly 1995, 3(2):148-155

Responsible Party: University of Chicago
ClinicalTrials.gov Identifier: NCT00000250     History of Changes
Other Study ID Numbers: NIDA-08391-2  R01DA008391  R01-08391-2 
Study First Received: September 20, 1999
Last Updated: May 26, 2015
Health Authority: United States: Federal Government

Keywords provided by University of Chicago:
nitrous oxide
choice
subjective effects
pain
analgesia
reinforcer
healthy volunteer

Additional relevant MeSH terms:
Disease
Substance-Related Disorders
Opioid-Related Disorders
Pathologic Processes
Chemically-Induced Disorders
Mental Disorders
Nitrous Oxide
Anesthetics, Inhalation
Anesthetics, General
Anesthetics
Central Nervous System Depressants
Physiological Effects of Drugs
Analgesics, Non-Narcotic
Analgesics
Sensory System Agents
Peripheral Nervous System Agents

ClinicalTrials.gov processed this record on December 02, 2016